Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 20 studies | 34% ± 16% | |
astrocyte | 16 studies | 41% ± 19% | |
microglial cell | 14 studies | 41% ± 13% | |
oligodendrocyte precursor cell | 13 studies | 38% ± 16% | |
glutamatergic neuron | 12 studies | 52% ± 25% | |
oligodendrocyte | 12 studies | 37% ± 14% | |
GABAergic neuron | 11 studies | 49% ± 25% | |
fibroblast | 10 studies | 33% ± 9% | |
adipocyte | 9 studies | 37% ± 12% | |
epithelial cell | 8 studies | 29% ± 15% | |
macrophage | 8 studies | 37% ± 14% | |
pericyte | 7 studies | 32% ± 12% | |
smooth muscle cell | 7 studies | 33% ± 7% | |
interneuron | 6 studies | 61% ± 25% | |
neuron | 5 studies | 54% ± 19% | |
endothelial cell of lymphatic vessel | 5 studies | 30% ± 7% | |
monocyte | 5 studies | 23% ± 5% | |
type I pneumocyte | 5 studies | 27% ± 7% | |
type II pneumocyte | 5 studies | 24% ± 6% | |
granule cell | 4 studies | 37% ± 8% | |
cardiac muscle cell | 4 studies | 28% ± 3% | |
amacrine cell | 4 studies | 35% ± 16% | |
retinal rod cell | 4 studies | 28% ± 8% | |
club cell | 4 studies | 27% ± 7% | |
GABAergic interneuron | 3 studies | 52% ± 3% | |
progenitor cell | 3 studies | 33% ± 3% | |
dendritic cell | 3 studies | 19% ± 2% | |
GABAergic amacrine cell | 3 studies | 38% ± 13% | |
glycinergic amacrine cell | 3 studies | 36% ± 12% | |
retina horizontal cell | 3 studies | 39% ± 13% | |
retinal ganglion cell | 3 studies | 40% ± 18% | |
myeloid cell | 3 studies | 22% ± 4% | |
hepatocyte | 3 studies | 51% ± 17% | |
connective tissue cell | 3 studies | 22% ± 4% | |
ependymal cell | 3 studies | 42% ± 19% | |
B cell | 3 studies | 25% ± 6% | |
T cell | 3 studies | 24% ± 2% | |
alveolar macrophage | 3 studies | 30% ± 7% | |
ciliated cell | 3 studies | 32% ± 10% | |
natural killer cell | 3 studies | 19% ± 3% | |
lymphocyte | 3 studies | 27% ± 8% | |
basal cell | 3 studies | 39% ± 21% | |
mesothelial cell | 3 studies | 37% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1771.20 | 459 / 459 | 100% | 11.16 | 1114 / 1118 |
esophagus | 100% | 1503.91 | 1445 / 1445 | 99% | 7.71 | 182 / 183 |
brain | 100% | 1597.67 | 2634 / 2642 | 100% | 10.87 | 703 / 705 |
thymus | 100% | 2467.64 | 653 / 653 | 99% | 8.94 | 599 / 605 |
ovary | 100% | 2671.67 | 180 / 180 | 99% | 7.21 | 425 / 430 |
lung | 99% | 1522.43 | 575 / 578 | 99% | 6.53 | 1147 / 1155 |
prostate | 100% | 1993.11 | 245 / 245 | 98% | 7.75 | 494 / 502 |
kidney | 100% | 1857.10 | 89 / 89 | 98% | 8.84 | 884 / 901 |
adrenal gland | 100% | 2346.62 | 257 / 258 | 97% | 6.87 | 224 / 230 |
bladder | 100% | 1759.43 | 21 / 21 | 97% | 6.24 | 487 / 504 |
pancreas | 99% | 895.44 | 324 / 328 | 98% | 6.48 | 174 / 178 |
intestine | 100% | 1550.48 | 966 / 966 | 96% | 5.59 | 507 / 527 |
stomach | 100% | 1185.40 | 358 / 359 | 96% | 6.11 | 274 / 286 |
skin | 100% | 1654.07 | 1807 / 1809 | 94% | 7.34 | 446 / 472 |
uterus | 100% | 1943.95 | 170 / 170 | 94% | 6.06 | 431 / 459 |
liver | 98% | 806.30 | 221 / 226 | 71% | 3.28 | 287 / 406 |
spleen | 100% | 1823.94 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.31 | 1 / 1 |
adipose | 100% | 1731.55 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1792.24 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 799.40 | 821 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 5.86 | 74 / 80 |
tonsil | 0% | 0 | 0 / 0 | 91% | 4.11 | 41 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 4.82 | 25 / 29 |
muscle | 71% | 332.82 | 571 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 57% | 509.26 | 525 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0006468 | Biological process | protein phosphorylation |
GO_0008283 | Biological process | cell population proliferation |
GO_0032006 | Biological process | regulation of TOR signaling |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0030496 | Cellular component | midbody |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0005524 | Molecular function | ATP binding |
GO_0004672 | Molecular function | protein kinase activity |
Gene name | TBCK |
Protein name | TBC domain-containing protein kinase-like protein TBC1 domain containing kinase |
Synonyms | DKFZp313C1916 HSPC302 TBCKL |
Description | FUNCTION: Involved in the modulation of mTOR signaling and expression of mTOR complex components . Involved in the regulation of cell proliferation and growth . Involved in the control of actin-cytoskeleton organization . . |
Accessions | ENST00000503516.1 ENST00000361687.8 [Q8TEA7-3] ENST00000505574.1 Q8TEA7 ENST00000394708.7 [Q8TEA7-1] Q5HYF5 D6R950 H0Y959 ENST00000273980.10 [Q8TEA7-1] ENST00000509862.5 ENST00000467183.6 H0YA45 ENST00000507696.1 D6RDG2 ENST00000503832.1 ENST00000509532.5 H0Y8U7 D6RDY5 D6RC61 ENST00000508666.5 ENST00000394706.7 [Q8TEA7-2] |